AAPM Recommends Against Use of Bismuth Shielding for CT Scanning
In a position statement, the American Association of Physicists in Medicine advise against using bismuth shields for dose reduction in CT scanning when alternatives are available.
Regular use of bismuth shields during CT scanning to protect anterior organs is not recommended by the American Association of Physicists in Medicine (AAPM) when alternatives for shielding are available.
Bismuth shielding has been traditionally used to shield radiosensitive organs such as the breast, lens of the eye and thyroid during CT scans.
“However, bismuth shielding degrades image quality, attenuates photons exiting the patient, and causes unpredictable results when combined with automatic exposure control systems,” the group said in a position statement released this week. Click here for a pdf of the full statement.
According to the AAPM, there are several known disadvantages to bismuth shield use, such as degrading image quality and accuracy, unpredictable and potentially undesirable levels of dose and image quality, and waste of some of the patient’s radiation exposure.
To avoid the use of the shield, suggestions include reducing the dose to the specific peripheral organs by adjusting automatic exposure controls (AEC) parameters and using organ-based tube current modulation techniques.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
